文献速递认知障碍与痴呆

衰弱与痴呆的关联:脑结构与免疫代谢特征的中介作用

Association of Frailty With Dementia and the Mediating Role of Brain Structure and Immunometabolic Signatures.
PubMed 文献 · Neurology · 2025-09-17

基于英国生物银行489,573名基线无痴呆参与者的前瞻性队列研究,中位随访13.58年记录8,900例痴呆。衰弱前期和衰弱分别与痴呆风险增加50%和182%相关,双向孟德尔随机化提示衰弱对痴呆的潜在因果关联,结构方程模型显示遗传背景、神经与免疫代谢功能可能介导该关联。

要点

  • 衰弱前期和衰弱分别与痴呆风险增加50%和182%相关。
  • 衰弱且高遗传风险者痴呆风险最高,APOE-ε4携带者HR达8.45。
  • 孟德尔随机化提示衰弱对痴呆存在潜在因果关联。

核心结论

  • 研究支持衰弱与痴呆存在因果关联,可能由遗传背景及神经与免疫代谢功能介导,但衰弱也可能仅是痴呆易感性的相关标志。

研究设计与样本

  • 前瞻性队列研究,基于英国生物银行2006至2010年入组、基线无痴呆的489,573名参与者,平均年龄57.03岁,女性占54.4%。
  • 衰弱按5项标准定义:体重下降、疲惫、体力活动不足、步速慢和握力低;通过医院入院记录和死亡登记用ICD-10编码追踪痴呆。
  • 采用Cox比例风险回归和双向孟德尔随机化评估因果关联,并用结构方程模型评估遗传背景、脑结构和生物标志物的作用。

主要发现

  • 中位随访13.58年共记录8,900例痴呆;相比非衰弱者,衰弱前期者痴呆风险高50%(HR 1.50,95%CI 1.44-1.57),衰弱者高182%(HR 2.82,95%CI 2.61-3.04)。
  • 衰弱且高多基因风险评分者相比低遗传风险且非衰弱者痴呆HR为3.87(95%CI 3.30-4.55),APOE-ε4携带者为8.45(95%CI 7.51-9.51)。
  • 正向孟德尔随机化提示衰弱与痴呆存在潜在因果关联(OR 1.79,95%CI 1.03-3.12),反向分析无因果关联(OR 1.00,95%CI 0.98-1.01)。
  • 结构方程模型提示遗传背景及神经与免疫代谢功能可能是连接衰弱与痴呆的潜在机制。

关键数值与推荐

  • 衰弱定义采用5项标准:体重下降、疲惫、体力活动不足、步速慢、握力低。
  • 痴呆结局通过医院入院记录和死亡登记中ICD-10编码确认。

临床怎么用

  • 在临床评估中可将衰弱状态作为痴呆风险分层的重要参考,尤其对衰弱前期和衰弱患者应加强认知监测。
  • 结合遗传风险(如多基因风险评分和APOE-ε4状态)与衰弱评估,有助于识别痴呆高风险个体。
  • 针对衰弱进行干预是否可降低痴呆风险,需进一步干预研究验证。

局限性

  • 作者指出衰弱也可能仅是痴呆易感性的相关标志,关联解释需谨慎。
  • 研究基于英国生物银行队列,结果外推至其他人群需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Physical frailty is associated with a higher risk of developing dementia, but it remains unclear whether this relationship is causal and whether the biological biomarkers and neurologic underlying mechanisms are involved. We aimed to elucidate the link between physical frailty and dementia, establish their causal relationship, and investigate the underlying biological mechanisms. METHODS: This prospective cohort study was based on UK Biobank participants without dementia at enrollment (between 2006 and 2010). Physical frailty was defined by 5 criteria (weight loss, exhaustion, physical inactivity, slow walking speed, and low grip strength). Incident dementia was tracked through linked hospital admission records and death registries, using the International Classification of Diseases, Tenth Revision (ICD-10) codes. Cox proportional hazard regression models and bidirectional Mendelian randomization (MR) analyses were used to evaluate the causal association of physical frailty with incident dementia. In addition, the potential roles of genetic background, brain structures, and biological biomarkers in the association were evaluated using structural equation modeling. RESULTS: Among 489,573 participants (mean age 57.03 years, 54.4% female), 8,900 dementia cases were documented over a median follow-up of 13.58 years. Compared with nonfrail individuals, the risk of dementia was 50% higher in those with prefrailty (hazard ratio [HR]:1.50, 95% CI 1.44-1.57) and 182% higher in those with frailty (HR: 2.82, 95% CI 2.61-3.04). Participants with frailty and high genetic risk had the highest risk of dementia compared with those with low genetic risk and nonfrailty (HR: 3.87, 95% CI 3.30-4.55 for high polygenic risk score; HR: 8.45, 95% CI 7.51-9.51 for APOE-ε4 carriers). The forward MR analysis indicated a potential causal relationship between physical frailty and dementia (odds ratio [OR]:1.79, 95% CI 1.03-3.12) while the reverse MR suggested a null causal association (OR: 1.00, 95% CI 0.98-1.01). Structural equation modeling points to genetic background and neurologic and immunometabolic function as potential underlying mechanisms linking physical frailty to dementia. DISCUSSION: Our findings support the causal association between physical frailty and dementia, which is possibly mediated through genetic background and neurologic and immunometabolic function. However, this association deserves close consideration because frailty may also be a correlative marker of dementia vulnerability.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Suo X, Li L, Guo J, et al. Association of Frailty With Dementia and the Mediating Role of Brain Structure and Immunometabolic Signatures. Neurology. 2025. PMID: 40961394. doi:10.1212/WNL.0000000000214199

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。